期刊文献+

急性髓系白血病治疗进展 预览 被引量:5

Progress in the treatment of acute myeloid leukemia
在线阅读 下载PDF
分享 导出
摘要 近年来的研究对于急性髓系白血病(AML)发病机制的理解已经有了显著的进步,导致AML发病的许多分子学异常逐渐明晰,因此对于AML的本质认识越来越深刻。与此同时大量临床试验的开展也获得了相当的成功,AML的诊治方案已经进展到了个体化阶段。 With the identification of numerous molecular abnormalities that may be responsible for leukemogenesis,the mechanisms leading to the development of acute myeloid leukemia (AML) has been maken remarkably progress,and there are more and more profound understandings of the nature of AML.At the same time a large number of clinical trials conducted has reaped considerable success,the diagnosis and treatment of AMLhas advanced to individual phase.
作者 张晋琳 ZHANG Jin-lin (Department of Haematology,Si. chuan Academy of Medical Sciences & Sichuan Provincial People's Hospital,Chengdu 610072,China )
出处 《实用医院临床杂志》 2010年第2期 46-50,共5页 Practical Journal of Clinical Medicine
关键词 急性髓系白血病 个体化治疗 预后评估 Acute myeloid leukemia Individualized therapy Assessment of prognosis
作者简介 张晋琳,女,主任医师,硕士生导师。四川省医师协会血液科专委会副主任委员。从事血液内科临床及研究工作。
  • 相关文献

参考文献15

  • 1Farag SS, Archer KJ, Mrozek K, et al. Pretreatment cytogeneticsadd to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia:resuits from Cancer and Leukemia Group B 8461 [ J]. Blood,2006, 108 ( 1 ) :63-73,. 被引量:1
  • 2Richard S,Garcia-Manero G,Ferrajoli A, et al. Use of alltrans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia[J]. Blood,2006,107(10) :3469-3473. 被引量:1
  • 3Sekeres MA, Elson P, Kalaycio ME, et al. Time from diagnosis to treatment initiation predicts survival in younger, but not older,acute myeloid leukemia patients[ J]. Blood ,2009,113 ( 1 ) :28-36. 被引量:1
  • 4Wiernik K, Marcucci G, Paschka P, et al. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogeneties : are we ready for a prognostieally prioritized molecular classfication [ J ]. Blood, 2007,109 ( 2 ) :431-448. 被引量:1
  • 5Baldus CD,Thiede C,Soucek S,et al. BAALC expression and FL33 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics : prognostic implications [ J ]. J Clin Oncol,2006, 24 ( 5 ) : 790 -797. 被引量:1
  • 6Vignetti RF, Corbaeioglu A, Krauter J, et al. Gene mutations as predictive markers for postremission therapy in younger adults with normal karyotype AML[ J ]. Blood ,2006,108 ( 1 ) :6a. 被引量:1
  • 7Paschka P, Marcucci G, Ruppert AS, et al, Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv and t( 8; 21 ) :a Cancer and Leukemia Group B Study[ J]. J Clin Oncol,2006,24 (24) :3904-3911. 被引量:1
  • 8Kern M,Estey S, Urbano-Ispizua A,et al. Genomic polymorphisms provide prognostic information in intermediaterisk acute myeloblastic leukemia [ J ]. Blood, 2006,107 ( 12 ) :4871-4879. 被引量:1
  • 9Ravandi F, Burnett A,Agura D, et al. Progress in the treatment of acute myeloid leukemia[ J]. Cancer,2007,110( 9 ) : 1900-1910. 被引量:1
  • 10Shinawi M, Erez A, Shardy DL, et al. Syndromic thrombocytopenia and predisposition to acute myelogenous leukemia caused by constitutional microdeletions on chromosome 21 q [ J ] . Blood, 2008, 112 ( 4 ) : 1042- 1047. 被引量:1

同被引文献69

  • 1赵妍敏,吴康妮,王颖佳,吴功强,曹伟杰,于晓红,黄河.雷帕霉素协同去甲氧柔红霉素诱导人急性T淋巴细胞白血病Jurkat细胞株凋亡的作用[J].浙江大学学报:医学版,2011(5):482-488. 被引量:2
  • 2ChesonBD,BennettJM,KopeckyKJ,周学慧,肖志坚.国际工作组关于急性髓系白血病治疗试验的诊断、疗效标准的标准化、治疗结局和报告标准的修订建议[J].白血病.淋巴瘤,2004,13(4):246-250. 被引量:26
  • 3张伯龙,黄文荣,达万明,张占强,姚善谦,高春记,韩晓萍,吴晓雄,王全顺,于力,张苗,靳海杰.双次自体造血干细胞移植治疗恶性血液病的临床分析[J].中华医学杂志,2002,82(2):123-126. 被引量:3
  • 4Chen XH ,Zhang C,Zhang X,et al. Role of antithymocyte globulin and granulocyte-colony stimulating factor mobilized bone marrow in allogeneic transplantation for patients with hematologic malig nancies[J]. Biol Blood Marrow Transplam, 2009,15 (2) :266-273. 被引量:1
  • 5Chen XH, Gao 1., Zhang X, et al. ttI.A haploidentical hlood and hone marrow transplantation with anti thymoeytc glohulirl=long term comparison with HLA-identlcal sibling transplantation[J]. Blood cell Mol Dis,2009,43(1) : 98-104. 被引量:1
  • 6Lapidot T,Sirard C,Vormoor J. A cell initiating human acute myeloid leukemia after transplantation into SCID mice[J].Nature,1994,(6464):645-648. 被引量:1
  • 7Sano H,Shimada A,Taki T. RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia,and related to late relapse:a study of the Japanese Childhood AML Cooperative Study Group[J].International Journal of Hematology,2012,(05):509-515. 被引量:1
  • 8Leung W,Hudson MM,Strickland DK. Late effects of treatment in survivors of childhood acute myeloid leukemia[J].Journal of Clinical Oncology,2000,(18):3273-3279. 被引量:1
  • 9Richard S,Garcia-Manero G,Ferrajoli A. Use of alltrans retinoic acid plus arsenic trioxide as an alternative to chemotherapy in untreated acute promyelocytic leukemia[J].Blood,2006,(09):3469-3473. 被引量:1
  • 10Boissel N,Leroy H,Brethon B. Incidence and prognostic impact of c-Kit,FLT3,and Ras gene mutations in core binding factor acute myeloid leukemia (CBF-AML)[J].Leukemia:Official Journal of the Leukemia Society of America,Leukemia Research Fund,U.K,2006,(06):965-970. 被引量:1

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈